RIPK1 and eosinophilia-myalgia syndrome: These findings suggest that RIPK1 not only plays a pivotal role in PANoptosis regulation but may also serve as a potential therapeutic target for modulating immune evasion and impaired tissue repair mechanisms in EMs pathogenesis (Figures 2A,B).